Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- AnaBios, a preclinical contract research organization that provides ex vivo human platforms to de-risk new drugs, today announced a technology transfer...
-
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AnaBios today announced the inaugural Translational Research Conference to be held Feb. 27-28, 2023, in San Diego, California. The conference will gather...
-
SAN DIEGO, June 14, 2022 (GLOBE NEWSWIRE) -- AnaBios is pleased to announce the hire of Blake Anson, Ph.D., as Vice President of Business Development. In this new role, Dr. Anson will contribute to...
-
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- AnaBios Corporation, a leading preclinical contract research organization (CRO) that focuses on translational research with unique capabilities to...
-
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Today, AnaBios announced it will start providing high-quality human primary liver cells to pharmaceutical, biotech and academic laboratories to further...
-
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded AnaBios a $1,734,409...